These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Not reported 2006-003685-33 Study of viro-immunological dynamics and T-lymphocyte homeostasis in peripheral blood in the pathogenesisof HIV infection and in the response to antiretroviral therapy. 2009-04-27 due-trials
Ongoing 2006-006588-21 Fluvastatin as adjuvant therapy to alfa-interferon and ribavirin in the treatment of chronic hepatitis C in patients with HIV-1 coinfection not-yet-due
Completed, but no date 2007-005330-37 Pharmacokinetics of atazanavir at the dose of 300mg or 400mg in subjects with HIV-1 infection and non-decompensated hepatic cirrhosis (Child-Pugh A o B, Metavir F4), crossover study. bad-data
Completed, but no date Terminated 2007-005698-76 Evaluation of chronic hepatitis C treatment with PEG-IFN ALFA-2a and ribavirin in HIV-positive subjects with persistently normal transaminase levels. bad-data
Ongoing 2007-005945-39 Phase II open label study of Pegaptanib sodium on patients with subfoveal choroidal neovascularization caused by pathologic myopia. not-yet-due
Ongoing 2008-001468-34 Phase III clinical trial multicenter randomized for the evaluation of the safety and efficacy of the combined treatment of intravitreal triamcinolone and photodynamic therapy versus intravitreal Bevac... not-yet-due
Ongoing 2008-001600-23 Prospective, randomized, single masked pilot study on the variation of choroidal blood flow analyzed through the HRA dynamic angiography in patients treated with intravitreal injection of Selective ... not-yet-due
Ongoing 2008-002246-33 Local application of mitomicin C for the treatment of stricturing CrohnÂ’s disease: a phase III, single-center, randomized clinical trial not-yet-due
Not reported 2008-002661-30 Use of Maraviroc (MVC) in immunogical non-responder HIV-1-infected patients. 2011-02-08 due-trials
Ongoing 2008-002978-35 Intensification of HAART with Maraviroc (MVC) as first line therapy of HIV-1-infected patients to rapidly suppress viral replication and minimize the evolution of drug-resistant variants not-yet-due
Ongoing 2008-004641-29 Non profit study of phase II randomized, double blind, placebo controlled, parallel groups, dose-finding trial with 3 different doses of Betaine versus placebo in subjects affected by PAD (Peripheral ... not-yet-due
Completed, but no date 2009-012499-28 Efficacy of the treatment with hydroxychloroquine in non responders HIV-infected HAART-treated patients bad-data
Ongoing 2010-019037-10 IcatibaNt In Treatment of Idiopathic Angio Edema. not-yet-due
Ongoing 2010-019670-32 Pharmacokinetics and Safety of Human Pasteurised C1-Inhibitor Concentrate (Berinert/CE1145) in Subjects with Congenital C1-INH Deficiency and Frequent Hereditary Angioedema (HAE) Attacks. not-yet-due
Ongoing 2011-000563-28 Randomized prospectic clinical trial for delivery induction in patients with unfavoreable obstetric conditions. not-yet-due
Ongoing 2011-000593-54 Effect of Vitamin D supplementation in HIV-infected children, adolescents and young adults with hypovitaminosis D. not-yet-due
Completed, but no date 2011-001682-41 Comparison of the efficacy and the safety of different schedules of administration of sub-lingual immunotherapy in patients with ragweed pollinosis: a phase III randomized and controlled clinical stud... bad-data
Ongoing 2011-002193-23 Long term Immunogenicity of Quadrivalent Human Papillomavirus vaccine (Gardasil) in HIV-infected adolescents and young adults vs. healthy adolescents and young adults: non-randomized controlled clinic... not-yet-due
Ongoing 2011-006251-11 Pilot clinical trial, controlled and randomized, Phase III, to evaluate security and efficacy of oral specific immunotherapy in HIV infected patients who suffer from grass pollen allergy. not-yet-due
Completed, but no date 2012-002509-23 Efficacia e Sicurezza di Eperisone Cloridrato come terapia in pazienti affetti da fibromialgia : Studio prospettico, monocentrico in doppio cieco, randomizzato, placebo controll bad-data
Ongoing 2012-004214-34 Comparison of efficacy and acceptability of bisacodil and PEG-CS 2 L and PEG 4 L in patients with chronic inflammatory bowel disease: single center, randomized, single blind, parallel groups study not-yet-due
Ongoing 2012-005192-14 Strategic study of dual-therapy with darunavir/ritonavir and rilpivirine QD versus triple-therapy in patients with suppressed viral load: virological efficacy and evaluation of non-HIV related morbidi... not-yet-due
Not reported 2013-002273-22 Efficacy of Pidotimod in the prevention of respiratory infections in healthy children: a randomized, double blind, placebo controlled study. 2014-11-25 due-trials
Ongoing 2014-000815-15 Effects of a late add-on therapy of pegylated interferon (peg-IFNA) to ongoing nucleos(t)ide not-yet-due
Ongoing 2014-002134-31 Evalutation of maraviroc therapy in PI-treated HIV+ patients at intermediate-low risk for cardiovascular diseases: a phase IV, randomized, open study not-yet-due